Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study to Evaluate the Safety and Antiviral Efficacy of Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care Treatment

NCT04334967 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.

NCT NCT04334967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study to Evaluate the Safety and Antiviral Efficacy of Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care Treatment
Lead sponsor
Providence Health & Services
Phase
Phase 4
Overall status
Suspended
Start date
March 30, 2020
Completion date
May 27, 2022
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

2019 novel coronavirus, 2019-ncov, corona virus infection, covid-19, sars-cov-2